Molecular Cancer Therapeutics Landon Prizes for Basic and Translational Cancer Research Bridging the Lab and the Clinic in Cancer Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sutter, T. R.
Right arrow Articles by Kensler, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sutter, T. R.
Right arrow Articles by Kensler, T. W.
Vol. 1, 1283-1292, December 2002     Molecular Cancer Therapeutics
© 2002 American Association for Cancer Research

Multiple Comparisons Model-based Clustering and Ternary Pattern Tree Numerical Display of Gene Response to Treatment: Procedure and Application to the Preclinical Evaluation of Chemopreventive Agents 1

Thomas R. Sutter2, Xiao-Rui He, Peter Dimitrov, Lijing Xu, Giri Narasimhan, E. Olusegun George, Carrie Hayes Sutter, Clinton Grubbs, Richard Savory, Markus Stephan-Gueldner, Dirk Kreder, Michael J. Taylor, Ronald Lubet, Tricia A. Patterson and Thomas W. Kensler

W. Harry Feinstone Center for Genomic Research [T. R. S., X-R. H., P. D., L. X., G. N., E. O. G., C. H. S.], Department of Mathematical Sciences [X-R. H., P. D., G. N., E. O. G.], University of Memphis, Memphis, Tennessee 38152; Chemoprevention Center, University of Alabama at Birmingham, Birmingham, Alabama 35294 [C. G.]; Roche, Welwyn, United Kingdom [R. S.]; F. Hoffman-La Roche AG, Basel, Switzerland [M. S-G.]; Roche Bioscience, Palo Alto, California 94304 [D. K., M. J. T.]; Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland 20852 [R. L.]; and Department of Environmental Health Sciences, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland 21205 [T. A. P., T. W. K.]

Microarray technology has greatly aided the identification of genes that are expressed differentially. Statistical analysis of such data by multiple comparisons procedures has been slow to develop, in part, because methods to cluster the results of such comparisons in biologically meaningful ways have not been available. We isolated and analyzed, by Northern blot and GeneChip, replicate liver RNA samples (n = 4/group) from rats fed with control diet or diet containing one of three chemopreventive compounds, selected because their pharmacological activities, including RNA expression response, are relatively well understood. We report on a classification tree, based on the results of nonparametric multiple comparisons, which results in the bipolar hierarchical clustering of genes in relation to their response to treatment. In addition to identifying treatment-responsive genes, application of this procedure to our test study identified the known pharmacological relationships among the treatment groups without supervision. Also, small treatment-specific subsets of genes were identified that may be indicative of additional pharmacophores present in the test compounds.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.